Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
glaxosmithkline
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
4
×
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
merck
translate bio
adverum biotechnologies
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
clinical trials
crispr-cas9
cystic fibrosis
deals
drug pricing
What
bio
roundup
4
×
crispr
ceo
drug
acquisitions
advanced
albert
alliance
arrival
award
big
biggest
bosley's
bosley’s
bourla
bridge
bristol
bucks
buy
calls
cancer
cas
changing
color
company
crime
data
days
death
decades
dems
departure
editas
exit
future
given
growing
guiding
hours
Language
unset
unknown
Current search:
roche
×
roundup
×
" new york top stories "
×
glaxosmithkline
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More